DEA
DXCM icon

DoubleLine ETF Adviser’s DexCom DXCM Stock Holding History

DoubleLine ETF Adviser’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Sell
4,193
-592
-12% -$39.4K 0.12% 150
2026
Q1 		$300K Buy
+4,785
New +$333K 0.11% 152

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DoubleLine ETF Adviser's DXCM Position: Q2 2026 in Review

DoubleLine ETF Adviser reduced its DexCom (DXCM) stake by 12% in Q2 2026, selling an estimated $39.4K and leaving 4,193 shares worth $282K. The position accounts for 0.12% of the portfolio, ranked #150.

DoubleLine ETF Adviser first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. The position peaked at $300K in Q1 2026. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • DoubleLine ETF Adviser held 4,193 shares of DexCom worth $282K as of Q2 2026.
  • DoubleLine ETF Adviser sold 592 DexCom shares in Q2 2026, an estimated $39.4K.
  • DexCom made up 0.12% of DoubleLine ETF Adviser's portfolio in Q2 2026, its #150 holding.
  • DoubleLine ETF Adviser first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
  • DoubleLine ETF Adviser's DexCom position peaked at $300K in Q1 2026.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.